Form 4 for RGEN REPLIGEN CORP
Accepted 2025-03-19 00:00:00 ET · period of report 2025-03-17 · accession 0000950170-25-042026 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2025-03-19 | 2025-03-17 | RGEN | Hunt Anthony | Dir | S - Sale+OE | $152.51 | -26.8K | 163.0K | -14% | -$4.08M |
| DMT | 2025-03-19 | 2025-03-17 | RGEN | Hunt Anthony | Dir | M - OptEx | $54.73 | +26.8K | 163.1K | +20% | +$1.46M |
| DMT | 2025-03-19 | 2025-03-17 | RGEN | Hunt Anthony | Dir | M - OptEx | $0.00 | -26.8K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-17 | S | D | 2,283 | $153.70 | 136,301 | D | — | — | (F6) $153.70 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $153.55 to $153.82, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 2 | Common | Common Stock | 2025-03-17 | S | D | 15,619 | $152.82 | 138,584 | D | — | — | (F5) $152.82 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $152.39 to $153.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range |
| 3 | Common | Common Stock | 2025-03-17 | S | D | 6,176 | $151.96 | 154,203 | D | — | — | (F4) $151.96 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $151.43 to $152.37, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 4 | Common | Common Stock | 2025-03-17 | S | D | 2,518 | $151.09 | 160,379 | D | — | — | (F3) $151.09 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.42 to $151.37, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 5 | Common | Common Stock | 2025-03-17 | S | D | 100 | $150.38 | 162,897 | D | — | — | |
| 6 | Common | Common Stock | 2025-03-17 | S | D | 60 | $148.05 | 162,997 | D | — | — | (F2) $148.05 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.01 to $148.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 7 | Common | Common Stock | 2025-03-17 | M | A | 5,000 | $33.87 | 141,301 | D | — | — | |
| 8 | Common | Common Stock | 2025-03-17 | M | A | 21,756 | $59.52 | 163,057 | D | — | — | |
| 9 | Derivative | Stock Option (Right to Buy) | 2025-03-17 | M | D | 5,000 | $0.00 | 202,344 | D | $33.87 · — to 2028-03-01 | 5,000 Common Stock | (F7) 207,344 of the shares underlying this option have vested. The remaining shares vest as follows: 28,777 shares on March 1, 2026, and 28,778 shares on March 1, 2027. |
| 10 | Derivative | Stock Option (Right to Buy) | 2025-03-17 | M | D | 21,756 | $0.00 | 0 | D | $59.52 · — to 2029-02-28 | 21,756 Common Stock | (F8) This option is fully vested and exercisable. |